News Archive

Launch of the Joint Action - INTEGRATE

19t September the Joint Action on integrating prevention, testing and link to care strategies across HIV, viral hepatitis, TB and STIs in Europe - INTEGRATE - will be launched.

INTEGRATE is funded by the 3rd EU Health Programme and will run over three years (September 2017-August 2020)

The main objective of INTEGRATE is to integrate early diagnosis and linkage to prevention and care of HIV, viral hepatitis, TB and STIs in EU member states by 2020.

Read mroe about the Joint Action INTEGRATE here
For more information follow INTEGRATE on Facebook and Twitter


New PERSIMUNE Publication

PERSIMUNE in publication in Nature genetics " Bayesian analysis of genetic association across
tree-structured routine healthcare data in the UK Biobank
." .
Professor Lars Fugger contributed to an analysis comparing classified phenotypes against findings from analysis 
of host genomics and report an improvement of more than 20% increase in power to detect genetic effects over other approaches and identifies new associations between classical human leukocyte antigen (HLA) alleles and common immune-mediated diseases (IMDs). The study emphasises that a more careful system biological characterisation (in this instance host genome bioinformatics analysis) contributes to a better and biologically-determined classification of causes of disease.  

Read the publication here

New EU project

CHIP will be the coordinator for the new EU funded Joint Action INTEGRATE. The launch of INTEGRATE will happen in Brussels 19 September 2017 where the EU commissioner for Food and Health will participate.
Read more here


CHIP Newsletter August 2017

Read the CHIP newsletter with the latest news and updates here


Available position as PhD student at CHIP

CHIP has an available position as a full-time PhD student for the newly formed multi-cohort collaboration RESPOND.
RESPOND is aiming at investigating effects of HIV, viral hepatitis co-infection, adverse drug effects and comorbidities on morbidity and mortality outcomes among people living with HIV.

Read more about the position and apply here

Deadline for application 31st August 2017

CHIP Newsletter!

Henceforth, CHIP will release newsletters on our homepage with regular intervals. Please find the first newsletter from May 2017 here! We hope you enjoy the read. 


HepHIV 2017 Conference, Malta 31 January to 2 February 2017

HIV in Europe presents the 2nd HepHIV conference:
HepHIV 2017 Conference: HIV and Viral Hepatitis: Challenges of Timely Testing and Care

CHIP was represented with 10 presentations! 4 oral presentations and 6 poster presentations. Please find them all HERE


CROI 2017

Conference on Retroviruses and Opportunistic Infections 13-16 February 2017

CHIP was represented with 7 presentations, 2 oral presentations, 1 themed discussion and 4 posters

Please find all presentations here


Press article on recent EuroSIDA findings

EuroSIDA study finds that new cancer rates climb with age in HIV patients, but age impact differs by cancer type. Read the press article in HIV Treatment Alerts HERE. (Article 3, page 9)

The press review is based on this EuroSIDA publication from 2016:

Infection-related and -unrelated malignancies, HIV and the aging population. abstract


CROI 2017 Webcast of press conference on D:A:D study results

Please find link below for webcast on the press conference on D:A:D study results presented at CROI 2017.

Webcast of press conference

Please find link for both D:AD presentations at CROI 2017 below:

Association between Cardiovascular Disease & Contemporarily Used Protease Inhibitors. 
presented by Lene Ryom on behalf of the D:A:D. study

Cessation of cigarette smoking and the impact on cancer incidence in the D:A:D Study. presented by Leah Shepherd on behalf of the D:A:D study 


PERSIMUNE Immunologic Colloquium 15 March 2017

The next Immunologic Colloquium will be 15 March 15.30-16.30
Department of Infectious Diseases, Rigshospitalet (8632)
Library room 3rd floor


Jens Lundgren receives the 2017 Hagedorn Prize

Jens Lundgren receives the 2017 Hagedorn Prize from Novo Nordisk Fonden for his pioneering and internationally recognized research on treatment for people living with HIV.

Press release

Novo Nordisk Fonden website (English)

Two-day course on Introduction to Cost-Effectivenes Analysis

A short 2-day course 28 -29 September 2017  on Introduction to Cost-effectiveness Analysis for Infectious Diseases. Read more about the course here


EACS online course on Clinical Management of HIV

6 week online course on Clinical Management of HIV.
Special moderated period 1 May - 9 June 2017.
Sign up today! 


PERSIMUNE Immunologic Colloquium 17 May 2017

The next immunologic colloquium will take place 17th May 2017, 15.30-16.30

Library room 3rd floor. Epidemiklinikken 8632

Please find agenda for the colloquium here

  Next page >